ArticleFrontiers in reproductive health2025
Hair care product use among pregnant women of color: protocol for a feasibility educational intervention.
Article in Frontiers in reproductive health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04493892 (Hair Care Product Use Among Women Of Color), which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Hair Care Product Use Among Women Of Color: A Northern Manhattan Intervention
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Endocrine-disrupting chemicals (EDCs) disrupt hormonal regulation and pose health risks. Phthalates, common in personal care products, contribute to disparate chemical exposures among different demographic groups, notably impacting critical life stages like pregnancy and postpartum. Objective: Using an environmental health literacy framework, we designed an educational intervention for pregnant Women of Color to highlight the health risks of phthalates in hair care products. The intervention aimed to measure behavioral changes toward phthalate-free products through self-reporting and urinary phthalate metabolite levels and explore factors influencing hair care practices during pregnancy. Methods: In collaboration with multidisciplinary academicians, environmental health, and breast cancer advocates, we developed a virtual educational intervention during the COVID-19 pandemic. Components included a facilitated presentation, an educational video, and a semi-structured interview guide that was refined through feedback. Data collection involved baseline and follow-up sessions, sociodemographic data, hair product usage, behavior related to phthalate-containing products, and urine sample collection. To provide proof of methodological principle, we examined individual change over time from questionnaire data and targeted exposomics analysis of urinary phthalate compounds among women with baseline and follow-up data. Results: Educational materials were developed in English and Spanish. Enrollment occurred from March 2021 to June 2022, involving participants in the second or third trimester of pregnancy. Women enrolled before 31 weeks gestation, completed a baseline assessment and at least one follow-up assessment, while those at ≥31 weeks gestation completed a baseline assessment and one postpartum follow-up assessment. Forty-six participants enrolled, with 31 completing the intervention, and 42 urine samples collected. Women who completed the educational intervention were slightly older than those women who did not attend an intervention session [mean age (SD) 31.0 (5.8) vs. 27.5 (5.4)], respectively. Product and brand use decreased over time, and portions of participants exhibited reductions in six different low molecular weight phthalate metabolites (27%-73% reductions). Significance: This intervention was shaped by a collaborative effort that ensured its cultural relevance, linguistic inclusivity, and alignment with community needs, amplifying its potential impact on reducing the unequal burden of environmental exposures in marginalized communities. Clinical Trial Registration: NCT04493892.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.